Nevertheless, supporting the long-term angiogenic efficacy of AD-MSCs in ischemic mouse tissues, FGF-2 modulates angiogenesis via an autocrine mechanism, and together with VEGF has a potent synergistic effect on the induction of angiogenesis in vivo [103]. The gene discussed is VEGFA; the disease is Alzheimer disease.